|
|
A fight to give hope to the terminally ill.
- Article from:
-
Chicago Tribune (Chicago, IL)
- Article date:
-
August 16, 2007
|
Copyright informationCOPYRIGHT 2007 Chicago Tribune. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: James Oliphant
WASHINGTON _ Arnie Mass is marching on Washington next month.
But the retired stockbroker isn't lining up for a political cause as much as he plans on doing some in-person lobbying at the doorstep of the Food and Drug Administration. Mass and his fellow protesters want an anti-cancer treatment approved by the FDA. And when do they want it? Now.
The treatment Mass is stumping for is called Provenge and it's billed as a vaccine to help treat prostate cancer. It has been stalled in what critics say is the FDA's byzantine drug-approval process. Mass and his organization, CareToLive, have had enough. They've resorted to launching Web campaigns ...